AcelRx Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Talphera

10/03/2022 22:02

* AcelRx Pharmaceuticals Inc  ACRX.OQ  reported a quarterly
adjusted loss of 6 cents​​ per share for the quarter ended in
December. The mean expectation of two analysts for the quarter
was for a loss of 7 cents per share.
    * Revenue fell 99.7% to $2.00 thousand from a year ago; 
analysts
expected $1.85 million. 
    * AcelRx Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 6 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * AcelRx Pharmaceuticals Inc shares had fallen by 21.6% this
quarter.
    * The company reported a quarterly loss of $7.92 million.
    * Wall Street's median 12-month price target for AcelRx
Pharmaceuticals Inc is $4.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 10 at 10:02 p.m.  ​All
figures in US dollars unless otherwise stated